TipRanks
Go Ultimate55% OFF

Atossa Therapeutics (0HJ7) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0HJ7 Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Atossa Therapeutics in the past 3 months

0HJ7 Stock 12 Month Forecast

$17.50▲(0.00% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Atossa Therapeutics in the last 3 months. The average price target is $17.50 with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a ― change from the last price of ―.
Highest Price Target$25.00Average Price Target$17.50Lowest Price Target$10.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0HJ7
Price TargetFollowArticle
Maxim Group$10buy―Reiterated10/09/26
Ascendiant$24→$25buy―Reiterated09/30/26
Rodman & Renshaw$12buy―Initiated07/07/26
Craig-Hallum$35→$10buy―Reiterated02/12/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Atossa Therapeutics

3 Months
Edward Woo
Edward WooAscendiant
Success Rate4/13 ratings generated profit
31%
Average Return
-9.95%

Copying Edward Woo's trades and holding each position for 3 Months would result in 30.77% of your transactions generating a profit, with an average return of -9.95% per trade.

1 Year
Edward Woo
Edward WooAscendiant
Success Rate3/13 ratings generated profit
23%
Average Return
-18.67%

Copying Edward Woo's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -18.67% per trade.

2 Years
Edward Woo
Edward WooAscendiant
Success Rate4/13 ratings generated profit
31%
Average Return
-47.30%

Copying Edward Woo's trades and holding each position for 2 Years would result in 30.77% of your transactions generating a profit, with an average return of -47.30% per trade.

0HJ7 Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0HJ7
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy53332
Buy00000
Hold11000
Sell00000
Strong Sell00000
total64332

In the current month, 0HJ7 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0HJ7 average Analyst price target in the past 3 months is 17.50.

0HJ7 Financial Forecast

$-3$-2.25$-1.5$-0.75$0Q4 2025Q2 2026Q3 2026
High$-0.74
Consensus$-0.86
Low$-1.05

0HJ7 Earnings Forecast

Next quarter’s earnings estimate for 0HJ7 is -$0.86 with a range of -$1.05 to -$0.74. The previous quarter’s EPS was -$0.95. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q3 2026
High$0.00
Consensus$0.00
Low$0.00

0HJ7 Sales Forecast

Next quarter’s sales forecast for 0HJ7 is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0HJ7 Stock Forecast FAQ

What is GB:0HJ7’s average 12-month price target, according to analysts?
Based on analyst ratings, Atossa Therapeutics’s 12-month average price target is $17.50.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Atossa Therapeutics a Buy, Sell or Hold?
Atossa Therapeutics has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Atossa Therapeutics’s share price target?
The average share price target for Atossa Therapeutics is $17.50. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $25.00, and the lowest forecast is $10.00. The average share price target represents a 0.00% increase from the current price of ―.
What do analysts say about Atossa Therapeutics?
Atossa Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Atossa Therapeutics?
To buy shares of GB:0HJ7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.